Can biomarkers improve outcomes for the asbestos-induced cancer malignant mesothelioma?
Can biomarkers improve outcomes for the asbestos-induced cancer malignant mesothelioma?
批准号:
nhmrc : GNT1063067
负责人:
Prof Anna Nowak
金额:
$51.28万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-01-01 至 2017-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The deadly asbestos-induced cancer mesothelioma is continuing to kill tens of thousands of people each year. Most patients are diagnosed with advanced disease. In this study we will use novel biomarkers to help the diagnosis of mesothelioma and potentially improve treatment options for patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving treatment outcomes for malignant mesothelioma patients using biomarkers.
-
批准号:nhmrc : 1063067
-
项目类别:Project Grants
-
资助金额:$53.03万
-
财政年份:2014
-
负责人:Prof Anna Nowak
-
依托单位:
Cross Presentation and tumour immunology
-
批准号:nhmrc : 1029589
-
项目类别:Project Grants
-
资助金额:$29.68万
-
财政年份:2012
-
负责人:Prof Anna Nowak
-
依托单位:
National Centre for Asbestos Related Diseases
-
批准号:nhmrc : 1001020
-
项目类别:Centres of Research Excellence
-
资助金额:$341.4万
-
财政年份:2010
-
负责人:Prof Anna Nowak
-
依托单位:
海外基金